Premium
PET‐ADAPTED NIVOLUMAB +/‐ ICE AS INITIAL SALVAGE THERAPY IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA
Author(s) -
Herrera A.F.,
Chen R.,
Palmer J.,
Tsai N.,
McBride K.,
Song J.,
Mei M.,
Zain J.,
Nikolaenko L.,
Popplewell L.,
Nademanee A.,
Rosen S.,
Kwak L.,
Lee H.,
Forman S.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.102_2630
Subject(s) - medicine , nivolumab , salvage therapy , refractory (planetary science) , oncology , clinical endpoint , surgery , clinical trial , chemotherapy , immunotherapy , cancer , physics , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom